FDA Adverse Event Injury Summary report: N

POWERLINK SYSTEM

MDR report key: 1994063 · Received February 16, 2011

Report

Report Number
2031527-2011-00007
Event Type
Injury
Date Received
February 16, 2011
Date of Event
January 3, 2011
Report Date
July 20, 2011
Manufacturer
ENDOLOGIX, INC.
Product Code
MIH
PMA / PMN Number
P040002
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

PATIENT IMPLANT ON (B)(6) 2010 OF A 25-16-100BL BIFURCATED DEVICE AND A 34MM AORTIC EXTENSION. A (B)(6) 2010 FOLLOW UP REVEALED A PROXIMAL TYPE I ENDOLEAK. ON (B)(6) 2011 THE PATIENT WAS TREATED WITH A 34MM AORTIC EXTENSION WHICH CORRECTED THE ENDOLEAK. SHOULD READ: PATIENT IMPLANT ON (B)(6) 2010 OF A 28-16-100BL BIFURCATED DEVICE AND A 34MM AORTIC EXTENSION. A (B)(6) 2010 FOLLOW UP REVEALED A PROXIMAL TYPE I ENDOLEAK. ON (B)(6) 2011 THE PATIENT WAS TREATED WITH A 34MM AORTIC EXTENSION WHICH CORRECTED THE ENDOLEAK. LOT# READS: W10-2615-002. LOT# SHOULD READ: W10-2615-002.

Additional Manufacturer Narrative · 1

REVIEW OF LOT RECORDS/WORK ORDERS, PRIOR REPORTS. NO ISSUES WERE NOTED. IT IS UNKNOWN IF THE PATIENT ANATOMY MET THE CRITERIA FOR INDICATIONS FOR USE. ENDOLEAKS ARE A KNOWN RISK OF THE PROCEDURE. NO CONCLUSION CAN BE DRAWN.

Description of Event or Problem · 1

PATIENT IMPLANT ON (B)(6) 2010 OF A 28-16-100BL BIFURCATED DEVICE AND A 34MM AORTIC EXTENSION. A (B)(6) 2010 FOLLOW UP REVEALED A PROXIMAL TYPE I ENDOLEAK. ON (B)(6) 2011, THE PATIENT WAS TREATED WITH A 34MM AORTIC EXTENSION WHICH CORRECTED THE ENDOLEAK.

Description of Event or Problem · 1

PATIENT IMPLANT ON (B)(6) 2010 OF A 25-16-100BL BIFURCATED DEVICE AND A 34MM AORTIC EXTENSION. A (B)(6) 2010 FOLLOW UP REVEALED A PROXIMAL TYPE I ENDOLEAK. ON (B)(6) 2011 THE PATIENT WAS TREATED WITH A 34MM AORTIC EXTENSION WHICH CORRECTED THE ENDOLEAK.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 POWERLINK SYSTEM SUPRARENAL PROXIMAL EXTENSION STENT GRAFT MIH ENDOLOGIX, INC. 34-34-100RLE W10-2615-002

Patients

Seq Age Sex Outcome Treatment
1 75 YR Required Intervention